The present invention encompasses compounds of general formula (1) wherein R
1
to R
3
and X are defined as in claim
1
, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.